OpenAlex
PricingAboutJobs
Log inGet started
Work

Initial injectable therapy in type 2 diabetes: Key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin

HTML

Year: 2019
Type: review
Source: Metabolism
DOI: 10.1016/j.metabol.2019.06.012
Authors: Anastasia-Stefania Alexopoulos, John B. Buse
Institutions: Duke Medical Center, University of North Carolina at Chapel Hill
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, GLP-1 receptor agonists, basal insulin, glycemic control, weight loss, hypoglycemia risk, cardiovascular benefits, self-monitoring of blood glucose, drug tolerability, drug discontinuation, health care costs, individualized treatment decision-making
SDG: Good health and well-being

Open Access status: green

Funders: European Association for the Study of Diabetes, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences
Awards: North Carolina Translational and Clinical Science Institute (NC TraCS), Endocrinology and Metabolism Training Program
OpenAlex ID: W2954613645
FWCI: 0.445
Cites: 85
Cited by: 27
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security